145 related articles for article (PubMed ID: 2934544)
1. Antiarthritic and immunoregulatory activity of spirogermanium.
DiMartino MJ; Lee JC; Badger AM; Muirhead KA; Mirabelli CK; Hanna N
J Pharmacol Exp Ther; 1986 Jan; 236(1):103-10. PubMed ID: 2934544
[TBL] [Abstract][Full Text] [Related]
2. Effect of auranofin treatment on aberrant splenic interleukin production in adjuvant arthritic rats.
Lee JC; Dimartino MJ; Votta BJ; Hanna N
J Immunol; 1987 Nov; 139(10):3268-74. PubMed ID: 3500212
[TBL] [Abstract][Full Text] [Related]
3. Suppressed IL-2 production and response in AA rats: role of suppressor cells and the effect of auranofin treatment.
Lee JC; Rebar L; Demuth S; Hanna N
J Rheumatol; 1985 Oct; 12(5):885-91. PubMed ID: 2935633
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activities of spirogermanium and other structurally related azaspiranes: effects on tumor cell and macrophage functions.
Mirabelli CK; Badger AM; Sung CP; Hillegass L; Sung CM; Johnson RK; Picker D; Schwartz D; Dorman J; Martellucci S
Anticancer Drug Des; 1989 Mar; 3(4):231-42. PubMed ID: 2930625
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
Kaplan JM; Badger AM; Ruggieri EV; Olivera DL; Newman-Tarr T; Bugelski PJ
J Clin Lab Immunol; 1991 Dec; 36(4):49-58. PubMed ID: 1668843
[TBL] [Abstract][Full Text] [Related]
6. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
Griswold DE; Lee JC; Poste G; Hanna N
J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519
[TBL] [Abstract][Full Text] [Related]
7. Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug.
Badger AM; Mirabelli CK; DiMartino M
Immunopharmacology; 1985 Dec; 10(3):201-7. PubMed ID: 2939040
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity.
High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM
J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis.
Johnson WJ; DiMartino MJ; Meunier PC; Muirhead KA; Hanna N
J Rheumatol; 1988; 15(5):745-9. PubMed ID: 3262750
[TBL] [Abstract][Full Text] [Related]
10. Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents.
Badger AM; Schwartz DA; Picker DH; Dorman JW; Bradley FC; Cheeseman EN; DiMartino MJ; Hanna N; Mirabelli CK
J Med Chem; 1990 Nov; 33(11):2963-70. PubMed ID: 2146392
[TBL] [Abstract][Full Text] [Related]
11. Splenic suppressor cells in adjuvant arthritic rats: effect of D-penicillamine.
Binderup L; Bramm E; Arrigoni-Martelli E
Agents Actions Suppl; 1980; 7():199-203. PubMed ID: 6454335
[TBL] [Abstract][Full Text] [Related]
12. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models.
Phadke K; Carlson DG; Gitter BD; Butler LD
J Immunol; 1986 Jun; 136(11):4085-91. PubMed ID: 3486226
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory activity and non-specific suppressor cell generation by spirogermanium in murine and rat models of cell-mediated immunity.
Badger AM; DiMartino MJ; Swift BA; Mirabelli CK
Immunopharmacology; 1988; 16(1):33-43. PubMed ID: 2971635
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of autoimmune disease and the generation of suppressor cells by spirogermanium: a biological profile similar to total lymphoid irradiation.
Badger AM; Mirabelli CK; Swift BA; DiMartino MJ
Agents Actions; 1989 Jun; 27(3-4):335-7. PubMed ID: 2529742
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.
Hill BT; Whatley SA; Bellamy AS; Jenkins LY; Whelan RD
Cancer Res; 1982 Jul; 42(7):2852-6. PubMed ID: 7200828
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiarthritic drugs on the enhanced interleukin-1 (IL-1) production by macrophages from adjuvant-induced arthritic (AA) rats.
DiMartino MJ; Johnson WJ; Votta B; Hanna N
Agents Actions; 1987 Aug; 21(3-4):348-50. PubMed ID: 3500597
[TBL] [Abstract][Full Text] [Related]
17. Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis.
Martini A; Ravelli A; Notarangelo LD; Maccario R; Lanfranchi A; Rondena D; Ugazio AG; Burgio R
J Rheumatol; 1986 Jun; 13(3):598-603. PubMed ID: 3090248
[TBL] [Abstract][Full Text] [Related]
18. Effect of metal containing compounds on superoxide release from phorbol myristate acetate stimulated murine peritoneal macrophages: inhibition by auranofin and spirogermanium.
Mirabelli CK; Sung CP; Picker DH; Barnard C; Hydes P; Badger AM
J Rheumatol; 1988 Jul; 15(7):1064-9. PubMed ID: 2845079
[TBL] [Abstract][Full Text] [Related]
19. The effect of SK&F 105685, a novel suppressor cell-inducing compound, in the adjuvant arthritic rat.
Badger AM; Swift BA; Bugelski PJ; High WB; DiMartino MJ; Greig R
Br J Rheumatol; 1991; 30 Suppl 2():66-9. PubMed ID: 1825183
[No Abstract] [Full Text] [Related]
20. Suppressor cell induction by the anticancer drug spirogermanium.
Badger AM; DiMartino MJ; Schmitt TC; Swift BA; Mirabelli CK
Int J Immunopharmacol; 1987; 9(5):621-30. PubMed ID: 2957334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
